does novo nordisk have a patent on semaglutide Ozempic's problem: how lost control of blockbuster drug. ๐ Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Semaglutide's patent expires today. What
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13



























